Patents Assigned to DS BIOPHARMA LIMITED
  • Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
    Patent number: 10570083
    Abstract: The present disclosure provides 15-oxo-EPA and 15-oxo-DGLA, compositions comprising 15-oxo-EPA and/or 15-oxo-DGLA, and methods of treating and/or preventing fibrosis, skin disorders, inflammation, kidney disease or renal dysfunction in a subject in need thereof by administering 15-oxo-EPA and/or 15-oxo-DGLA.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: February 25, 2020
    Assignee: DS Biopharma Limited
    Inventors: Mehar Manku, John Climax, David Coughlan
  • Pharmaceutically acceptable salts of fatty acids
    Patent number: 10544088
    Abstract: The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: January 28, 2020
    Assignee: DS Biopharma Limited
    Inventors: Mehar Manku, David Coughlan, Bill Downes
  • Pharmaceutical compositions comprising DGLA and use of same
    Patent number: 10537543
    Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: January 21, 2020
    Assignee: DS Biopharma Limited
    Inventors: Mehar Manku, John Climax, David Coughlan, James Dunne
  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 10328046
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: June 25, 2019
    Assignee: DS Biopharma Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Pharmaceutical compositions comprising DGLA and use of same
    Patent number: 10105333
    Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: October 23, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Mehar Manku, John Climax, David Coughlan, James Dunne
  • Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
    Patent number: 10047033
    Abstract: The present disclosure provides 15-oxo-EPA and 15-oxo-DGLA, compositions comprising 15-oxo-EPA and/or 15-oxo-DGLA, and methods of treating and/or preventing fibrosis, skin disorders, inflammation, kidney disease or renal dysfunction in a subject in need thereof by administering 15-oxo-EPA and/or 15-oxo-DGLA.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: August 14, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Mehar Manku, John Climax, David Coughlan
  • Pharmaceutically acceptable salts of fatty acids
    Patent number: 10017453
    Abstract: The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: July 10, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Mehar Manku, David Coughlan, Bill Downes
  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 9889106
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: February 13, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
    Patent number: 9855236
    Abstract: The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: January 2, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Mehar Manku, John Climax, David Coughlan